STAT3 and prostate carcinoma: Additionally, PGG inhibits STAT3 phosphorylation, resulting in the downregulation of downstream target Bcl-XL and Mcl-1, induces caspase-mediated apoptosis in prostate cancer cells in vitro, and decreases in vivo tumor xenograft growth [19].